Influence of propylene glycol and isopropyl myristate on the in vitro percutaneous penetration of diclofenac sodium from carbopol gels.

The influence of propylene glycol (PG) on the in vitro penetration of diclofenac sodium (DFS) through a synthetic membrane and abdominal rat skin from carbopol gels was investigated using Franz-type diffusion cells. The combined effect of isopropyl myristate (IPM) and PG was also evaluated. It was found that the penetration through the synthetic membrane was well described by the Higuchi model. The gel containing 40% PG showed the highest release rate, indicating that a releasing maximum exists for PG content which provides the fully solubilized drug in the vehicle. When using rat skin as the barrier, the penetration rate was controlled by the membrane. DFS flux decreased with increasing PG content of the gels due to an increase of the drug affinity to the vehicle. A cosolvent action of PG was evident. However, the combination of PG and IPM resulted in a synergistic enhancement of DFS flux. Maximum enhancing activity was obtained from gels containing 40% PG, which yielded an enhancement ratio of about 8. Increasing IPM content from 3 to 5% increased the flux and decreased the lag time taken to reach a steady-state level.

[1]  J. Zatz,et al.  Evaluation of penetration enhancement of lidocaine by nonionic surfactants through hairless mouse skin in vitro. , 1986, Journal of pharmaceutical sciences.

[2]  J. Bouwstra,et al.  Changes in lipid organisation of the skin barrier by N-alkyl-azocycloheptanones : a visualisation and X-ray diffraction study , 1996 .

[3]  R. Guy,et al.  On the determination of drug release rates from topical dosage forms , 1990 .

[4]  B. W. Barry,et al.  Action of skin penetration enhancers—the Lipid Protein Partitioning theory , 1988, International journal of cosmetic science.

[5]  C. Leopold,et al.  An Attempt to Clarify the Mechanism of the Penetration Enhancing Effects of Lipophilic Vehicles with Differential Scanning Calorimetry (DSC) * , 1995, The Journal of pharmacy and pharmacology.

[6]  A. Kaneko,et al.  In vitro percutaneous absorption of thiamine disulfide from a mixture of propylene glycol and fatty acid. , 1992, Journal of pharmaceutical sciences.

[7]  W. Higuchi.  Analysis of data on the medicament release from ointments. , 1962, Journal of pharmaceutical sciences.

[8]  Y. Kato,et al.  Effects of fatty acids, fatty amines and propylene glycol on rat stratum corneum lipids and proteins in vitro measured by fourier transform infrared/attenuated total reflection (FT-IR/ATR) spectroscopy. , 1992, Chemical & pharmaceutical bulletin.

[9]  Jonathan Hadgraft,et al.  Development of model membranes for percutaneous absorption measurements. I. Isopropyl myristate , 1987 .

[10]  Y. Nakano,et al.  Rat percutaneous transport of diclofenac and influence of hydrogenated soya phospholipids. , 1987, Chemical & pharmaceutical bulletin.

[11]  B. W. Barry,et al.  Effect of penetration enhancers on the permeation of mannitol, hydrocortisone and progesterone through human skin , 1987, The Journal of pharmacy and pharmacology.

[12]  S. Santoyo,et al.  Penetration enhancer effects on the in vitro percutaneous absorption of piroxicam through rat skin , 1995 .

[13]  H. Maibach,et al.  Percutaneous Absorption: Mechanisms-Methodology-Drug Delivery , 1989 .

[14]  H. Sunada,et al.  Influence of fatty acid-alcohol esters on percutaneous absorption of hydrocortisone butyrate propionate. , 1988, Chemical & pharmaceutical bulletin.

[15]  H O Ho,et al.  The Influence of Cosolvents on the In‐vitro Percutaneous Penetration of Diclofenac Sodium From a Gel System , 1994, The Journal of pharmacy and pharmacology.

[16]  J. Brussee,et al.  Thermodynamic and structural aspects of the skin barrier , 1991 .

[17]  S. Santoyo,et al.  In vitro percutaneous absorption of piroxicam through synthetic membranes and abdominal rat skin. , 1996, Pharmaceutica acta Helvetiae.

[18]  E. R. Cooper,et al.  Increased skin permeability for lipophilic molecules. , 1984, Journal of pharmaceutical sciences.

[19]  A. Sallmann,et al.  Pharmacological properties of diclofenac sodium and its metabolites. , 1978, Scandinavian journal of rheumatology. Supplement.

[20]  T. Higuchi,et al.  Physical Chemical analysis of Percutaneous Absorption Process from Creams and Ointments , 1960 .

[21]  S. Santoyo,et al.  Enhancing effect of terpenes on the in vitro percutaneous absorption of diclofenac sodium , 1996 .

[22]  Michael Goodman,et al.  Lipid-protein-partitioning (LPP) theory of skin enhancer activity: finite dose technique , 1989 .

[23]  J. Nightingale,et al.  Enhanced transdermal delivery of estradiol in vitro using binary vehicles of isopropyl myristate and short-chain alkanols , 1995 .

[24]  R. Neubert,et al.  Influence of propylene glycol as cosolvent on mechanisms of drug transport from hydrogels , 1995 .

[25]  K. Sugibayashi,et al.  Effect and mode of action of aliphatic esters on the in vitro skin permeation of nicorandil , 1988 .

[26]  B. Lippold.  How to optimize drug penetration through the skin. , 1992, Pharmaceutica acta Helvetiae.

[27]  A. Ghanem,et al.  The effects of ethanol on the transport of lipophilic and polar permeants across hairless mouse skin: Methods/validation of a novel approach , 1992 .

[28]  T. Nagai,et al.  Combined effect of cyclic monoterpenes and ethanol on percutaneous absorption of diclofenac sodium. , 1991, Drug design and discovery.

[29]  A. IJzerman,et al.  Kinetics, ultrastructural aspects and molecular modelling of transdermal peptide flux enhancement by N-alkylazacycloheptanones , 1991 .

[30]  S. Goodwill,et al.  Solubility and in vitro percutaneous absorption of tetracaine from solvents of propylene glycol and saline , 1993 .